A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer

Cancer - Prostate, Cancer
Seth Kaufman, MD

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on your prostate cancer.
Intermediate risk prostate cancer; no prior radical surgery for prostate cancer or prior hormonal therapy
Rae Lynn Defeo